Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China.
Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China; Department of Biomedical Engineering, University of Minnesota, Minnesota, United States.
Nanomedicine. 2018 Jun;14(4):1087-1098. doi: 10.1016/j.nano.2018.02.007. Epub 2018 Feb 21.
Accurate and efficient antigen delivery is crucial for inducing a strong and long-term immune response. A visible protein nanovaccine made from antigen could provide a novel and promising technology for secure and efficient delivery of the antigen with imaging visualization. In this study, a functional nanovaccine based on genipin crosslinked ovalbumin (OVA) fluorescent nanoparticles with chitosan (CS-OVA-NPs) was developed. The nanovaccine can carry abundant antigens by self-crosslinking without additional carriers. The fluorescence imaging technique was applied to monitor and reveal the process of antigen delivery in vivo based on the fluorescence of genipin with a non-invasive and real-time manner. This functional OVA nanovaccine can enhance the uptake of OVA in Dendritic Cells (DCs) and further promote DCs to maturate in vitro. In vivo study further indicated CS-OVA-NPs could trigger antigen-specific immune responses, which demonstrated that this fluorescent nanovaccine provided a novel design approach for accurate and efficient vaccine delivery.
准确高效的抗原递呈对于诱导强烈而持久的免疫反应至关重要。由抗原制成的可见蛋白纳米疫苗为安全有效地递呈抗原并进行成像可视化提供了新颖而有前途的技术。在本研究中,开发了一种基于京尼平交联卵清蛋白(OVA)荧光纳米颗粒与壳聚糖(CS-OVA-NPs)的功能性纳米疫苗。该纳米疫苗可通过自身交联携带丰富的抗原,而无需额外的载体。荧光成像技术可应用于基于京尼平的荧光进行非侵入性和实时监测和揭示体内抗原递呈过程。这种功能性 OVA 纳米疫苗可增强树突状细胞(DCs)对 OVA 的摄取,并进一步促进 DCs 在体外成熟。体内研究进一步表明 CS-OVA-NPs 可引发抗原特异性免疫反应,这表明这种荧光纳米疫苗为准确高效的疫苗递送提供了新的设计方法。